02/23/2026 | Press release | Distributed by Public on 02/23/2026 10:44
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act File Number: 811-23494
T. Rowe Price Exchange-Traded Funds, Inc.
(Exact name of registrant as specified in charter)
1307 Point Street, Baltimore, MD 21231
(Address of principal executive offices)
David Oestreicher
1307 Point Street, Baltimore, MD 21231
(Name and address of agent for service)
Registrant's telephone number, including area code: (410) 345-2000
Date of fiscal year end: December 31
Date of reporting period: December 31, 2025
Item 1. Reports to Shareholders
(a) Report pursuant to Rule 30e-1
Annual Shareholder Report
December 31, 2025
This annual shareholder report contains important information about Capital Appreciation Equity ETF (the "fund") for the period of January 1, 2025 to December 31, 2025. You can find the fund's prospectus, financial information on Form N-CSR (which includes required tax information for dividends), holdings, proxy voting information, and other information at www.troweprice.com/prospectus. You can also request this information without charge by contacting T. Rowe Price at 1-800-638-5660 or [email protected]or by contacting your intermediary.
|
Fund name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
|
Capital Appreciation Equity ETF
|
$33
|
0.31%
|
Major U.S. stock market indexes rose in 2025. After a challenging start to the year, the market climbed the proverbial wall of worry, overcoming concerns about tariffs, the economy, conflicts in the Middle East and Ukraine, the longest federal government shutdown in U.S. history, and heightened valuations among artificial intelligence (AI)-related companies.
Versus the S&P 500 Index, an underweight allocation to the consumer staples sector contributed to relative results. While the sector advanced, returns were modest and lagged the broader benchmark during a risk-on period where markets favored higher growth and names with exposure to AI. Stock choices in materials also added value, where positions in Vulcan and Linde were beneficial.
On the negative side, stock choices in health care information technology detracted. Within health care, our position in Becton, Dickinson & Company weighed on relative results, as uncertainty surrounding research funding and the impact of tariffs weighed heavily on the health care equipment and supplies industry. In information technology, software company Roper declined and lagged peers amid investor preference for names with higher growth potential and more significant exposure to the AI trade.
The fund seeks long-term capital growth by investing primarily in common stocks of large U.S. companies. Notable changes in positioning during the period included adding to positions in health care and information technology.
|
ETF (Based on Net Asset Value)
|
Regulatory Benchmark
|
Strategy Benchmark
|
|
|
6/14/23
|
10,000
|
10,000
|
10,000
|
|
6/30/23
|
10,208
|
10,179
|
10,183
|
|
9/30/23
|
9,912
|
9,848
|
9,850
|
|
12/31/23
|
11,057
|
11,036
|
11,002
|
|
3/31/24
|
12,132
|
12,142
|
12,163
|
|
6/30/24
|
12,593
|
12,533
|
12,684
|
|
9/30/24
|
13,331
|
13,313
|
13,431
|
|
12/31/24
|
13,372
|
13,664
|
13,754
|
|
3/31/25
|
13,009
|
13,019
|
13,167
|
|
6/30/25
|
14,210
|
14,449
|
14,607
|
|
9/30/25
|
15,188
|
15,631
|
15,794
|
|
12/31/25
|
15,450
|
16,007
|
16,213
|
202505-4541202, 202601-5112276
ETF1072-052 02/26
|
Fund
|
1 Year
|
Since Inception 6/14/23
|
|
Capital Appreciation Equity ETF (Based on Net Asset Value)
|
15.54%
|
18.61%
|
|
Russell 3000 Index (Regulatory Benchmark)
|
17.15%
|
20.27%
|
|
S&P 500 Index (Strategy Benchmark)
|
17.88%
|
20.87%
|
The preceding line graph shows the value of a hypothetical $10,000 investment in the fund over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The fund's performance information included in the line graph and table above is compared with a regulatory required index that represents an overall securities market (Regulatory Benchmark). In addition, the line graph and table may also include one or more indexes that more closely aligns to the fund's investment strategy (Strategy Benchmark(s)). The fund's total return figures reflect the reinvestment of dividends and capital gains, if any. Neither the fund's returns nor the index returns reflect the deduction of taxes that a shareholder would pay on fund distributions or redemptions of fund shares. The fund's past performance is not a good predictor of the fund's future performance.Updated performance information can be found at www.troweprice.com.
|
Information Technology
|
34.2%
|
|
Health Care
|
17.7
|
|
Financials
|
11.5
|
|
Consumer Discretionary
|
11.0
|
|
Utilities
|
10.0
|
|
Communication Services
|
8.4
|
|
Industrials & Business Services
|
3.9
|
|
Energy
|
1.4
|
|
Consumer Staples
|
0.9
|
|
Other
|
1.0
|
|
NVIDIA
|
7.6%
|
|
Microsoft
|
7.4
|
|
Apple
|
5.9
|
|
Amazon.com
|
5.5
|
|
Alphabet
|
5.4
|
|
Meta Platforms
|
3.0
|
|
Broadcom
|
2.8
|
|
Becton Dickinson & Company
|
2.8
|
|
CenterPoint Energy
|
2.7
|
|
NiSource
|
2.6
|
If you invest directly with T. Rowe Price, you can elect to receive future shareholder reports or other important documents through electronic delivery by enrolling at www.troweprice.com/paperless. If you invest through a financial intermediary such as an investment advisor, a bank, retirement plan sponsor or a brokerage firm, please contact that organization and ask if it can provide electronic delivery.
Frank Russell Company "LSE" and S&P do not accept any liability for any errors or omissions in the indexes or data, and hereby expressly disclaim all warranties of originality, accuracy, completeness, timeliness, merchantability and fitness for a particular purpose. No party may rely on any indexes or data contained in this communication. Visit www.troweprice.com/en/us/market-data-disclosuresfor additional legal notices & disclaimers.
Capital Appreciation Equity ETF (TCAF)
T. Rowe Price Investment Services, Inc.
1307 Point Street
Baltimore, Maryland 21231
Principal Listing Exchange: NYSE Arca, Inc.
Item 1. (b) Notice pursuant to Rule 30e-3.
Not applicable.
Item 2. Code of Ethics.
The registrant has adopted a code of ethics, as defined in Item 2 of Form N-CSR,applicable to its principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of this code of ethics is filed as an exhibit to this Form N-CSR.No substantive amendments were approved or waivers were granted to this code of ethics during the period covered by this report.
Item 3. Audit Committee Financial Expert.
The registrant's Board of Directors has determined that Mr. Paul F. McBride qualifies as an audit committee financial expert, as defined in Item 3 of Form N-CSR.Mr. McBride is considered independent for purposes of Item 3 of Form N-CSR.
Item 4. Principal Accountant Fees and Services.
(a) - (d) Aggregate fees billed for the last two fiscal years for professional services rendered to, or on behalf of, the registrant by the registrant's principal accountant were as follows:
| 2025 | 2024 | |||||||||
|
Audit Fees |
$ | 23,735 | $ | 23,525 | ||||||
|
Audit-Related Fees |
- | - | ||||||||
|
Tax Fees |
125 | - | ||||||||
|
All Other Fees |
- | - | ||||||||
Audit fees include amounts related to the audit of the registrant's annual financial statements and services normally provided by the accountant in connection with statutory and regulatory filings. Audit-related fees include amounts reasonably related to the performance of the audit of the registrant's financial statements and specifically include the issuance of a report on internal controls and, if applicable, agreed-upon procedures related to fund acquisitions. Tax fees include amounts related to services for tax compliance, tax planning, and tax advice. The nature of these services specifically includes the review of distribution calculations and the preparation of Federal, state, and excise tax returns. All other fees include the registrant's pro-ratashare of amounts for agreed-upon procedures in conjunction with service contract approvals by the registrant's Board of Directors/Trustees.
(e)(1) The registrant's audit committee has adopted a policy whereby audit and non-auditservices performed by the registrant's principal accountant for the registrant, its investment adviser, and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant require pre-approvalin advance at regularly scheduled audit committee meetings. If such a service is required between regularly scheduled audit committee meetings, pre-approvalmay be authorized by one audit committee member with ratification at the next scheduled audit committee meeting. Waiver of pre-approvalfor audit or non-auditservices requiring fees of a de minimis amount is not permitted.
(2) No services included in (b) - (d) above were approved pursuant to paragraph (c)(7)(i)(C) of Rule 2-01of Regulation S-X.
(f) Less than 50 percent of the hours expended on the principal accountant's engagement to audit the registrant's financial statements for the most recent fiscal year were attributed to work performed by persons other than the principal accountant's full-time, permanent employees.
(g) The aggregate fees billed for the most recent fiscal year and the preceding fiscal year by the registrant's principal accountant for non-auditservices rendered to the registrant, its investment adviser, and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant were $1,862,000 and $1,262,000, respectively.
(h) All non-auditservices rendered in (g) above were pre-approvedby the registrant's audit committee. Accordingly, these services were considered by the registrant's audit committee in maintaining the principal accountant's independence.
(i) Not applicable.
(j) Not applicable.
Item 5. Audit Committee of Listed Registrants.
Not applicable.
Item 6. Investments.
(a) Not applicable. The complete schedule of investments is included in Item 7 of this Form N-CSR.
(b) Not applicable.
Item 7. Financial Statements and Financial Highlights for Open-EndManagement Investment Companies.
(a - b) Report pursuant to Regulation S-X.
| T. ROWE PRICE | |
| TCAF | Capital Appreciation Equity ETF |
| For more insights from T. Rowe Price investment professionals, go totroweprice.com. |
|
Year Ended |
6/14/23(1) Through |
||
| 12/31/25 | 12/31/24 | 12/31/23 | |
| NET ASSET VALUE | |||
| Beginning of period | $ 33.20 | $ 27.57 | $ 25.00 |
| Investment activities | |||
| Net investment income(2)(3) | 0.25 | 0.24 | 0.15 |
| Net realized and unrealized gain/loss | 4.91 | 5.53 | 2.49 |
| Total from investment activities | 5.16 | 5.77 | 2.64 |
| Distributions | |||
| Net investment income | (0.19) | (0.14) | (0.07) |
| NET ASSET VALUE | |||
| End of period | $ 38.17 | $ 33.20 | $ 27.57 |
| Ratios/Supplemental Data | |||
| Total return, based on NAV(3)(4) | 15.54% | 20.94% | 10.57% |
|
Ratios to average net assets:(3) |
|||
|
Gross expenses before waivers/payments by Price Associates |
0.31% | 0.31% | 0.31%(5) |
|
Net expenses after waivers/payments by Price Associates |
0.31% | 0.31% | 0.31%(5) |
| Net investment income | 0.70% | 0.77% | 1.04%(5) |
| Portfolio turnover rate(6) | 29.3% | 14.3% | 18.5% |
|
Net assets, end of period (in thousands) |
$ 6,334,984 | $ 3,046,031 | $ 669,903 |
| (1) | Inception date |
| (2) | Per share amounts calculated using average shares outstanding method. |
| (3) | Includes the impact of expense-related arrangements with Price Associates. |
| (4) | Total return reflects the rate that an investor would have earned on an investment in the fund during each period, assuming reinvestment of all distributions. Total return is not annualized for periods less than one year. |
| (5) | Annualized |
| (6) | Portfolio turnover excludes securities received or delivered through in-kind share transactions. |
| PORTFOLIO OF INVESTMENTS‡ | Shares | $ Value |
| (Cost and value in $000s) | ||
| COMMON STOCKS 99.9% | ||
| COMMUNICATION SERVICES 8.4% | ||
| Interactive Media & Services 8.4% | ||
| Alphabet, Class A | 1,071,811 | 335,477 |
| Alphabet, Class C | 18,734 | 5,879 |
| Meta Platforms, Class A | 285,422 | 188,404 |
| Total Communication Services | 529,760 | |
| CONSUMER DISCRETIONARY 11.0% | ||
| Broadline Retail 5.5% | ||
| Amazon.com (1) | 1,515,690 | 349,852 |
| 349,852 | ||
| Diversified Consumer Services 0.2% | ||
| Service International | 138,951 | 10,834 |
| 10,834 | ||
| Hotels, Restaurants & Leisure 5.2% | ||
| Chipotle Mexican Grill (1) | 273,948 | 10,136 |
| DoorDash, Class A (1) | 159,132 | 36,040 |
| Hilton Worldwide Holdings | 103,375 | 29,694 |
| Marriott International, Class A | 55,536 | 17,230 |
| Starbucks | 1,493,929 | 125,804 |
| Yum! Brands | 735,999 | 111,342 |
| 330,246 | ||
| Textiles, Apparel & Luxury Goods 0.1% | ||
| NIKE, Class B | 46,871 | 2,986 |
| 2,986 | ||
| Total Consumer Discretionary | 693,918 | |
| Shares | $ Value | |
| (Cost and value in $000s) | ||
| CONSUMER STAPLES 0.9% | ||
| Beverages 0.9% | ||
| Keurig Dr Pepper | 2,124,760 | 59,514 |
| Total Consumer Staples | 59,514 | |
| ENERGY 1.4% | ||
| Oil, Gas & Consumable Fuels 1.4% | ||
| Canadian Natural Resources | 2,672,547 | 90,466 |
| Total Energy | 90,466 | |
| FINANCIALS 11.5% | ||
| Banks 1.0% | ||
| JPMorgan Chase | 189,590 | 61,090 |
| 61,090 | ||
| Capital Markets 3.3% | ||
| Blackrock | 15,856 | 16,971 |
| Blackstone | 125,534 | 19,350 |
| Intercontinental Exchange | 11,656 | 1,888 |
| KKR | 673,468 | 85,854 |
| MSCI | 31,959 | 18,336 |
| S&P Global | 128,928 | 67,376 |
| 209,775 | ||
| Financial Services 3.5% | ||
| Mastercard, Class A | 204,275 | 116,616 |
| Visa, Class A | 307,858 | 107,969 |
| 224,585 | ||
| Insurance 3.7% | ||
| Arthur J. Gallagher | 399,731 | 103,446 |
| Ryan Specialty Holdings | 291,667 | 15,059 |
| Shares | $ Value | |
| (Cost and value in $000s) | ||
| Willis Towers Watson | 349,953 | 114,995 |
| 233,500 | ||
| Total Financials | 728,950 | |
| HEALTH CARE 17.7% | ||
| Biotechnology 3.1% | ||
| Apogee Therapeutics (1) | 114,912 | 8,674 |
| Arcellx (1) | 345,637 | 22,535 |
| Biogen (1) | 90,813 | 15,982 |
| BioNTech, ADR (1) | 191,493 | 18,230 |
| Cytokinetics (1) | 1,374,628 | 87,344 |
| Gilead Sciences | 213,103 | 26,156 |
| Vaxcyte (1) | 445,616 | 20,561 |
| 199,482 | ||
| Health Care Equipment & Supplies 5.9% | ||
| Abbott Laboratories | 1,223,654 | 153,312 |
| Becton Dickinson & Company | 917,367 | 178,033 |
| Medkine, Class A (1) | 404,091 | 16,972 |
| Stryker | 53,585 | 18,833 |
| Ypsomed Holding (CHF) | 9,679 | 3,982 |
| 371,132 | ||
| Health Care Providers & Services 3.9% | ||
| Cencora | 340,342 | 114,951 |
| McKesson | 28,305 | 23,218 |
| UnitedHealth Group | 328,915 | 108,578 |
| 246,747 | ||
| Life Sciences Tools & Services 2.9% | ||
| Danaher | 130,662 | 29,911 |
| Revvity | 835,884 | 80,872 |
| Thermo Fisher Scientific | 90,342 | 52,349 |
| Waters (1) | 8,899 | 3,380 |
| Shares | $ Value | |
| (Cost and value in $000s) | ||
| West Pharmaceutical Services | 57,320 | 15,771 |
| 182,283 | ||
| Pharmaceuticals 1.9% | ||
| Eli Lilly | 98,681 | 106,051 |
| Zoetis | 133,263 | 16,767 |
| 122,818 | ||
| Total Health Care | 1,122,462 | |
| INDUSTRIALS & BUSINESS SERVICES 3.9% | ||
| Aerospace & Defense 0.2% | ||
| Lockheed Martin | 26,035 | 12,592 |
| 12,592 | ||
| Commercial Services & Supplies 0.7% | ||
| Republic Services | 77,722 | 16,471 |
| Veralto | 166,875 | 16,651 |
| Waste Connections | 61,718 | 10,823 |
| 43,945 | ||
| Electrical Equipment 0.5% | ||
| AMETEK | 59,863 | 12,291 |
| Eaton | 66,683 | 21,239 |
| 33,530 | ||
| Machinery 2.1% | ||
| Fortive | 608,561 | 33,599 |
| Ingersoll-Rand | 1,009,024 | 79,935 |
| Otis Worldwide | 183,664 | 16,043 |
| 129,577 | ||
| Professional Services 0.4% | ||
| Booz Allen Hamilton | 96,523 | 8,143 |
| Equifax | 42,063 | 9,127 |
| Shares | $ Value | |
| (Cost and value in $000s) | ||
| Verisk Analytics | 43,688 | 9,772 |
| 27,042 | ||
| Total Industrials & Business Services | 246,686 | |
| INFORMATION TECHNOLOGY 34.2% | ||
| Electronic Equipment, Instruments & Components 1.2% | ||
| Amphenol, Class A | 423,311 | 57,206 |
| TE Connectivity | 68,725 | 15,636 |
| Teledyne Technologies (1) | 5,709 | 2,916 |
| 75,758 | ||
| IT Services 0.2% | ||
| Gartner (1) | 40,556 | 10,231 |
| 10,231 | ||
| Semiconductors & Semiconductor Equipment 13.6% | ||
| Advanced Micro Devices (1) | 590,277 | 126,414 |
| Broadcom | 519,003 | 179,627 |
| KLA | 18,135 | 22,035 |
| NVIDIA | 2,595,493 | 484,060 |
| Taiwan Semiconductor Manufacturing, ADR | 169,194 | 51,416 |
| 863,552 | ||
| Software 13.3% | ||
| Aurora Innovation (1) | 6,912,379 | 26,543 |
| Autodesk (1) | 57,623 | 17,057 |
| Bentley Systems, Class B | 781,842 | 29,839 |
| Cadence Design Systems (1) | 9,188 | 2,872 |
| Intuit | 16,728 | 11,081 |
| Microsoft | 973,266 | 470,691 |
| PTC (1) | 902,259 | 157,182 |
| Roper Technologies | 61,244 | 27,262 |
| Salesforce.com | 164,504 | 43,579 |
| Tyler Technologies (1) | 6,936 | 3,149 |
| Shares | $ Value | |
| (Cost and value in $000s) | ||
| Workday (1) | 234,510 | 50,368 |
| 839,623 | ||
| Technology Hardware, Storage & Peripherals 5.9% | ||
| Apple | 1,384,551 | 376,404 |
| 376,404 | ||
| Total Information Technology | 2,165,568 | |
| MATERIALS 0.8% | ||
| Chemicals 0.7% | ||
| Linde | 104,104 | 44,389 |
| 44,389 | ||
| Construction Materials 0.1% | ||
| Vulcan Materials | 30,716 | 8,761 |
| 8,761 | ||
| Total Materials | 53,150 | |
| REAL ESTATE 0.1% | ||
| Specialized REITs 0.1% | ||
| American Tower, REIT | 18,486 | 3,246 |
| Total Real Estate | 3,246 | |
| UTILITIES 10.0% | ||
| Electric Utilities 2.1% | ||
| Entergy | 163,331 | 15,097 |
| PPL | 3,330,794 | 116,644 |
| 131,741 | ||
| Multi-Utilities 7.9% | ||
| Ameren | 1,290,804 | 128,900 |
| CenterPoint Energy | 4,542,277 | 174,151 |
| NiSource | 3,894,595 | 162,638 |
| Shares | $ Value | |
| (Cost and value in $000s) | ||
| WEC Energy Group | 329,476 | 34,746 |
| 500,435 | ||
| Total Utilities | 632,176 | |
| Total Common Stocks (Cost $5,864,972) | 6,325,896 | |
| SHORT-TERM INVESTMENTS 0.1% | ||
| Money Market Funds 0.1% | ||
| T. Rowe Price Government Reserve Fund, 3.77% (2)(3) | 7,382,450 | 7,382 |
| Total Short-Term Investments (Cost $7,382) | 7,382 | |
|
Total Investments in Securities 100.0% of Net Assets (Cost $5,872,354) |
$6,333,278 | |
| ‡ | Shares are denominated in U.S. dollars unless otherwise noted. |
| (1) | Non-income producing. |
| (2) | Seven-day yield |
| (3) | Affiliated Companies |
| ADR | American Depositary Receipts |
| CHF | Swiss Franc |
| REIT | A domestic Real Estate Investment Trust whose distributions pass-through with original tax character to the shareholder |
| Affiliate |
Net Realized Gain (Loss) |
Changes in Net Unrealized Gain/Loss |
Investment Income |
| T. Rowe Price Government Reserve Fund | $- | $- | $263 |
| Totals | $-# | $- | $263+ |
| Supplementary Investment Schedule | ||||
| Affiliate |
Value 12/31/24 |
Purchase Cost |
Sales Cost |
Value 12/31/25 |
| T. Rowe Price Government Reserve Fund | $4,932 | ¤ | ¤ | $7,382 |
| Total | $7,382^ | |||
| # | Capital gain distributions from underlying Price funds represented $0 of the net realized gain (loss). |
| + | Investment income comprised $263 of dividend income and $0 of interest income. |
| ¤ | Purchase and sale information not shown for cash management funds. |
| ^ | The cost basis of investments in affiliated companies was $7,382. |
| Assets | |
| Investments in securities, at value (cost $5,872,354) | $6,333,278 |
| Receivable for shares sold | 7,635 |
| Dividends receivable | 3,265 |
| Total assets | 6,344,178 |
| Liabilities | |
| Payable for investment securities purchased | 7,541 |
| Investment management and administrative fees payable | 1,653 |
| Total liabilities | 9,194 |
| NET ASSETS | $6,334,984 |
| Net Assets Consists of: | |
| Total distributable earnings (loss) | $310,651 |
|
Paid-in capital applicable to 165,950,000 shares of $0.0001 par value capital stock outstanding; 4,000,000,000 shares of the Corporation authorized |
6,024,333 |
| NET ASSETS | $6,334,984 |
| NET ASSET VALUE PER SHARE | $38.17 |
|
Year Ended |
|
| 12/31/25 | |
| Investment Income (Loss) | |
| Income | |
| Dividend (net of foreign taxes of $857) | $48,425 |
| Interest | 2 |
| Total income | 48,427 |
| Investment management and administrative expense | 14,787 |
| Net investment income | 33,640 |
| Realized and Unrealized Gain / Loss | |
| Net realized gain (loss) | |
| Securities | (144,576) |
| In-kind redemptions | 540,421 |
| Foreign currency transactions | (24) |
| Net realized gain | 395,821 |
| Change in net unrealized gain / loss | |
| Securities | 301,126 |
| Other assets and liabilities denominated in foreign currencies | 8 |
| Change in unrealized gain / loss | 301,134 |
| Net realized and unrealized gain / loss | 696,955 |
| INCREASE IN NET ASSETS FROM OPERATIONS | $730,595 |
|
Year Ended |
|||
| 12/31/25 | 12/31/24 | ||
| Increase (Decrease) in Net Assets | |||
| Operations | |||
| Net investment income | $33,640 | $13,792 | |
| Net realized gain | 395,821 | 134,893 | |
| Change in net unrealized gain / loss | 301,134 | 120,049 | |
| Increase in net assets from operations | 730,595 | 268,734 | |
| Distributions to shareholders | |||
| Net earnings | (31,470) | (12,898) | |
| Capital share transactions* | |||
| Shares sold | 5,300,689 | 2,961,199 | |
| Shares redeemed | (2,710,861) | (840,907) | |
| Increase in net assets from capital share transactions | 2,589,828 | 2,120,292 | |
| Net Assets | |||
| Increase during period | 3,288,953 | 2,376,128 | |
| Beginning of period | 3,046,031 | 669,903 | |
| End of period | $6,334,984 | $3,046,031 | |
| *Share information (000s) | |||
| Shares sold | 148,750 | 93,300 | |
| Shares redeemed | (74,550) | (25,850) | |
| Increase in shares outstanding | 74,200 | 67,450 |
| ($000s) | Level 1 | Level 2 | Level 3 | Total Value |
| Assets | ||||
| Common Stocks | 6,321,914 | $3,982 | $- | 6,325,896 |
| Short-Term Investments | 7,382 | - | - | 7,382 |
| Total | $6,329,296 | $3,982 | $- | $6,333,278 |
| ($000s) | ||
| December 31, | December 31, | |
| 2025 | 2024 | |
| Ordinary income (including short-term capital gains, if any) | $31,470 | $12,898 |
| ($000s) | |
| Cost of investments | $5,885,072 |
| Unrealized appreciation | $583,443 |
| Unrealized depreciation | (135,237) |
| Net unrealized appreciation (depreciation) | $448,206 |
| ($000s) | |
| Net unrealized appreciation (depreciation) | $448,206 |
| Loss carryforwards and deferrals | (137,555) |
| Total distributable earnings (loss) | $310,651 |
Item 8. Changes in and Disagreements with Accountants for Open-EndManagement Investment Companies.
Not applicable.
Item 9. Proxy Disclosures for Open-EndManagement Investment Companies.
Not applicable.
Item 10. Remuneration Paid to Directors, Officers, and Others of Open-EndManagement Investment Companies.
Remuneration paid to Directors is included in Item 7 of this Form N-CSR.
Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract.
If applicable, see Item 7.
Item 12. Disclosure of Proxy Voting Policies and Procedures for Closed-EndManagement Investment Companies.
Not applicable.
Item 13. Portfolio Managers of Closed-EndManagement Investment Companies.
Not applicable.
Item 14. Purchases of Equity Securities by Closed-EndManagement Investment Company and Affiliated Purchasers.
Not applicable.
Item 15. Submission of Matters to a Vote of Security Holders.
There has been no change to the procedures by which shareholders may recommend nominees to the registrant's board of directors.
Item 16. Controls and Procedures.
(a) The registrant's principal executive officer and principal financial officer have evaluated the registrant's disclosure controls and procedures within 90 days of this filing and have concluded that the registrant's disclosure controls and procedures were effective, as of that date, in ensuring that information required to be disclosed by the registrant in this Form N-CSRwas recorded, processed, summarized, and reported timely.
(b) The registrant's principal executive officer and principal financial officer are aware of no change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.
Item 17. Disclosure of Securities Lending Activities for Closed-EndManagement Investment Companies.
Not applicable.
Item 18. Recovery of Erroneously Awarded Compensation.
Not applicable.
Item 19. Exhibits.
| (a)(1) |
N-CSR |
|
| (2) |
Listing standards relating to recovery of erroneously awarded compensation: not applicable. |
|
| (3) |
30a-2(a) |
|
| (b) |
30a-2(b) |
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| T. Rowe Price Exchange-Traded Funds, Inc. | ||||
| By |
/s/ David Oestreicher |
|||
| David Oestreicher | ||||
| Principal Executive Officer | ||||
| Date | February 18, 2026 | |||
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| By |
/s/ David Oestreicher |
|||
| David Oestreicher | ||||
| Principal Executive Officer | ||||
| Date |
February 18, 2026 |
|||
| By |
/s/ Alan S. Dupski |
|||
| Alan S. Dupski | ||||
| Principal Financial Officer | ||||
| Date |
February 18, 2026 |
|||